Skip to main content

Peer Review reports

From: Osimertinib showed efficacy on contralateral multiple ground-glass nodules after segmentectomy for lung adenocarcinoma harboring primary EGFR-T790M mutation: a case report and review of the literature

Original Submission
18 Jun 2022 Submitted Original manuscript
6 Jul 2022 Reviewed Reviewer Report - Miao Zhang
13 Jul 2022 Reviewed Reviewer Report
28 Aug 2022 Author responded Author comments - Jianbin Zhang
Resubmission - Version 2
28 Aug 2022 Submitted Manuscript version 2
Publishing
9 Dec 2022 Editorially accepted
19 Dec 2022 Article published 10.1186/s13019-022-02071-7

You can find further information about peer review here.

Back to article page